Viru-Chord
- Product NDC
- 64578-0125
- Requested package NDC
- 64578-0125-1
- 11-digit product format
- 645780125
- Labeler code
- 64578
- Product ID
- 64578-0125_44af0695-5390-439c-b50a-f720b8305bf9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Belladonna, Cinchona Officinalis, Echinacea (Angustifolia), Gelsemium Sempervirens, Glandula Suprarenalis Suis, Glycyrrhiza Glabra, Hepar Suis, Hydrastis Canadensis, Illicium Anisatum, Influenzinum, Lachesis Mutus, Lappa Major, Magnesia Phosphorica, Morbillinum, Myrrha, Nasturtium Aquaticum, Nux Vomica, Paloondo, Pyridoxinum Hydrochloricum, Riboflavinum, Sambucus Nigra, Scutellaria Lateriflora, Thiaminum Hydrochloricum, Thyroidinum (Bovine)
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Energetix Corp
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2016-02-15
- Marketing end
- 2021-03-08
- Substance
- ATROPA BELLADONNA; CINCHONA OFFICINALIS BARK; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; SUS SCROFA ADRENAL GLAND; GLYCYRRHIZA GLABRA; PORK LIVER; GOLDENSEAL; STAR ANISE; INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); LACHESIS MUTA VENOM; ARCTIUM LAPPA ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MEASLES VIRUS; MYRRH; NASTURTIUM OFFICINALE; STRYCHNOS NUX-VOMICA SEED; LARREA TRIDENTATA LEAF; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SAMBUCUS NIGRA FLOWERING TOP; SCUTELLARIA LATERIFLORA; THIAMINE HYDROCHLORIDE; THYROID, BOVINE
- Active strength
- 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 64578-0125 | 64578-0125-1 | D | Discontinued by firm | 2026-09-14 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 64578-0125-1 | 64578012501 | 59.1 mL in 1 BOTTLE, DROPPER (64578-0125-1) | 59.1 ml | 2016-02-15 | 2021-03-08 | No | No | Current |